Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

ラニチジンと肝毒性について

J E Hegarty

    Lancet (London, England)
    |January 26, 1985
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Corrigendum to "An emerging evidence base for the management of neonatal hypoglycemia" [Early Hum. Dev. 2017; 104: 51-56].

    Early human development·2017
    Same author

    Hypercalcaemia in leukaemia.

    Irish journal of medical science·2016
    Same author

    Low incidence of Pneumocystis jirovecii pneumonia in an unprophylaxed liver transplant cohort.

    Transplant infectious disease : an official journal of the Transplantation Society·2013
    Same author

    Chronic hepatitis C infection blocks the ability of dendritic cells to secrete IFN-α and stimulate T-cell proliferation.

    Journal of viral hepatitis·2011
    Same author

    The advent of successful organ transplantation in the Irish HIV positive cohort.

    Irish journal of medical science·2011
    Same author

    Anti-CD25 antibodies (daclizumab) as renal sparing immunosuppression after liver transplantation.

    Alimentary pharmacology & therapeutics·2011
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る